Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for asthma.

Phillip Factor1

  • 1Section of Pulmonary and Critical Care Medicine, Evanston Northwestern Healthcare and Northwestern University Feinberg School of Medicine, 2650 Ridge Road, Evanston, IL 60201, USA. pfactor@northwestern.edu

Molecular Therapy : the Journal of the American Society of Gene Therapy
|February 25, 2003
PubMed
Summary

Gene therapy offers a promising new approach to treating asthma by targeting airway inflammation. By redirecting immune responses, it aims to provide long-lasting relief and reduce medication reliance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interventional Pulmonology: Determining an Ideal Technique, Phenotype-driven Management, and Finding Safer Alternatives.

American journal of respiratory and critical care medicine·2017
Same author

Management strategies to effect change in intensive care units: lessons from the world of business. Part III. Effectively effecting and sustaining change.

Annals of the American Thoracic Society·2014
Same author

Management strategies to effect change in intensive care units: lessons from the world of business. Part II. Quality-improvement strategies.

Annals of the American Thoracic Society·2014
Same author

Management strategies to effect change in intensive care units: lessons from the world of business. Part I. Targeting quality improvement initiatives.

Annals of the American Thoracic Society·2014
Same author

Prenatal and postnatal polycyclic aromatic hydrocarbon exposure, airway hyperreactivity, and Beta-2 adrenergic receptor function in sensitized mouse offspring.

Journal of toxicology·2014
Same author

A 35-year-old woman with unusual behavior and prolonged respiratory failure.

Chest·2013

Area of Science:

  • Immunology
  • Pulmonology
  • Gene Therapy

Background:

  • Asthma is characterized by chronic airway inflammation, IgE production, and eosinophil recruitment, leading to airway hyper-reactivity.
  • Current asthma treatments have limitations, making alternative therapies like gene therapy a logical pursuit.
  • Understanding the immunopathology of asthma has revealed key pathways, such as CD4+ T cell polarization to a type-2 phenotype, driving disease progression.

Purpose of the Study:

  • To review recent advancements in gene transfer strategies for treating asthma in experimental models.
  • To highlight mechanism-based immunomodulatory and supportive gene therapy approaches.
  • To explore the potential of gene therapy in interrupting asthma pathophysiology.

Main Methods:

  • Review of experimental models utilizing gene transfer to the bronchial epithelium.

Related Experiment Videos

  • Focus on redirecting CD4+ T cell polarization from a type-2 to a type-1 phenotype.
  • Analysis of immunomodulatory and supportive gene transfer strategies.

    • Main Results:

    • Gene transfer in animal models has shown potential in redirecting immune responses away from harmful type-2 polarization.
    • These approaches aim to mitigate airway inflammation and associated pathologies like IgE production and eosinophil activation.
    • Successful gene transfer can lead to a less injurious, type-1 immune phenotype.

    Conclusions:

    • Gene therapy holds promise for interrupting the underlying mechanisms of airway inflammation in asthma.
    • Despite challenges in airway gene transfer, it offers a potential route to long-lasting protection against bronchospastic challenges.
    • Successful gene therapy could reduce patient dependence on inhaled and oral asthma medications.